Vimarsana
Biggest News Aggregation in the World

Optimized Workflows News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Optimized Workflows. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Optimized Workflows Today - Breaking & Trending Today

Biosense Webster launches HELIOSTAR™ in Europe, the first radiofrequency Balloon Ablation Catheter, enabling physicians to perform more efficient cardiac ablations - Vimarsana News

Biosense Webster launches HELIOSTAR™ in Europe, the first radiofrequency Balloon Ablation Catheter, enabling physicians to perform more efficient cardiac ablations

Biosense Webster, Inc., part of Johnson & Johnson MedTech, today announced the European launch of the HELIOSTAR™ Balloon Ablation Catheter.

Biosense Webster Launches HELIOSTAR™ in Europe, the First Radiofrequency Balloon Ablation Catheter, Enabling Physicians to Perform More Efficient Cardiac Ablations - Vimarsana News

Biosense Webster Launches HELIOSTAR™ in Europe, the First Radiofrequency Balloon Ablation Catheter, Enabling Physicians to Perform More Efficient Cardiac Ablations

/PRNewswire/ -- Biosense Webster, Inc., part of Johnson & Johnson MedTech†, today announced the European launch of the HELIOSTAR™ Balloon Ablation Catheter –...

µPAC™ micro-Chip tech key enabler in Single Cell Proteomics - Vimarsana News

µPAC™ micro-Chip tech key enabler in Single Cell Proteomics

Industry News: PharmaFluidics announces ultra-sensitive second generation µPAC™ technology for unbiased single-cell proteomics 18 Feb 2021 PharmaFluidics has announced that researchers of Karl Mechtler’s Group at the Research Institute for Molecular Pathology in Vienna have integrated its ultra-sensitive second generation µPAC™ micro-Chip technology as a key enabler in their advanced Single Cell Proteomics workflow. A newly published joint study available on bioRxiv discloses a 10-fold increase in detection sensitivity, achieved using PharmaFluidics’ second generation µPAC™ tech...